Biopharma veteran to advise Sei’s $65m Open Sc
Author: Michael
Neuronascent has published the Phase 1a clinical
Seragon Biosciences has launched Enlivien®, a no
Seraphina Therapeutics has achieved a notable ran
PhotoPharmics said that enrollment in its Light f
Seal Rock Therapeutics, a clinical-stage company
Omniscope launches osLongevity in pivot from imm
New summit seeks to shape the future of longevit
Cognition Therapeutics received end-of-Phase 2 me
Gameto, a clinical-stage biotechnology company de